Synevo

Genetic testing detects a variant of the F13A1 gene, whichóry contains instructions for producing one part of a protein called coagulation factor XIII. The V34L sequence variant is a factor in preventing pulmonary embolism, deep vein thrombosis and myocardial infarction.

The test involves the determination in the blood of a compound called tissue-specific polypeptide (TPS), and it is used in the diagnosis and monitoring of the course of some cancersóalthough it can be detected in other conditions, such as pregnancy.

The test involves the determination in the blood of beta-carotene, an organic compound called provitamin A, whichóry has the following actions in the body: antioxidant, anticancer, antimicrobial, immune-supporting

The test measures in a 24-hour collectionóurine levels of vanillin-malic acid (VMA), important for the diagnosis of pheochromocytoma tumors.

A urine test that measures cobalt levels, used to assess heavy metal exposure, for example, in people with cobalt-containing endoprostheses due to endoprosthesis wear.

A urine test that measures the level of tróichloroacetic acid, used in assessing exposure to chemicals.

The urine test measures the level of mianserin and is used in monitoring therapy and in cases of suspected poisoning with this drug.

A urine test to measure copper levels, important in diagnosing Wilson's disease.

A urine test that detects the presence of cocaine and its metabolitesóused in the diagnosis of poisoning.